Business Case

Investigated adoption pain points for an appetite suppressant and their impact on adoption / adherence to underpin financial modeling and inform strategic commercialization investment at a small biotech

A small pharmaceutical company specializing in obesity and metabolic disorders sought to develop their launch strategy and planning by understanding the patient journey and potential adoption of their lead asset, an appetite suppressant. LSC meticulously mapped the patient journey, identified pain points, and modeled the net potential adoption, emphasizing areas like diagnosis, referral, eligibility, and adherence. The outcome was a comprehensive view across several markets, detailing country-level patient journeys, and a quantified estimation of the “net” potential of our client’s leading asset both at full adoption and over a span of five years.